Although both WD-treated groups showed significantly higher levels of serum cholesterol, the cohort treated with NMTi had lower levels of serum alanine aminotransferase (ALT; Fig. 8b), suggestive of reduced liver damage. The gene discussed is GPT; the disease is Wilson disease.